List

Senruis Biotechnology (Shenzhen) Co., Ltd. was established in 2019 and is an international high-tech company engaged in research and development as well as production in the field of synthetic biology.

Yongyuan Hesheng is a data-driven synthetic biology innovation company that takes long-segment DNA synthesis technology as its entry point. Established in 2022, it adopts a revolutionary technological approach to establish a new generation of long-segment DNA synthesis platform, meeting the disruptive IT (Information Technology) + BT (Biotechnology) research and development paradigm needs, and driving the innovation of synthetic biology and genome engineering.

Shenzhen Wannong Source Code Biotechnology Co., Ltd., founded on May 27, 2025, is registered at 3rd Floor, No. 229, Gongchang Road, Zhenmei Community, Xinhu Street, Guangming District, Shenzhen.

Zhongkeling Carbon is invested by the Industrial Fund of the Chinese Academy of Sciences Shenzhen Advanced Technology Research Institute. It takes negative carbon technology to empower enterprises to reduce carbon and increase foreign exchange, promote the transformation of production methods of traditional high carbon emission enterprises, and help the national dual carbon policy and sustainable development strategy as its own responsibility; We are committed to developing a new generation of cell factory carbon neutrality technology driven by new energy, as well as a carbon capture/conversion integrated technology based on low-energy consumption chemistry, through the reconstruction of human low-carbon life using synthetic bioelectrochemistry. We aim to achieve resource utilization of carbon reduction and turning carbon dioxide waste into treasure, and provide technical solutions for systematic engineering that integrates green low-carbon, clean energy, ecological carbon sink, and circular economy.

Shenzhen Boya Gene Technology Co., Ltd. is a biotechnology startup focused on the research and clinical translation of gene therapy drugs, with a focus on chronic diseases and functional degenerative diseases that seriously affect the health of a large number of elderly people. Our gene drug uses adenovirus associated virus (AAV) as a delivery technology.